The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the methods of preparation, pharmaceutical composition, combinations and the use of compound formula (I), their stereoisomers, isotopic forms or pharmaceutically acceptable salts thereof. (I)
本发明涉及化合物(I)的公式,或其同位素形式、立体异构体、互变异构体或其药学上可接受的盐,作为肌动蛋白M1受体正向变构调节剂(M1 P
AMs)。本发明描述了制备方法、药物组合物、组合物的使用以及化合物公式(I)、其立体异构体、同位素形式或其药学上可接受的盐的使用。 (I)